Jan 23 (Reuters) - Marinus Pharmaceuticals Inc
* Marinus announces positive preliminary data from children with cdkl5 genetic disorder
* Marinus announces positive preliminary data from children with cdkl5 genetic disorder
* Marinus pharmaceuticals inc- enrollment is continuing in study with top-line data expected in mid-2017 Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.